“…Few studies using animal models of renal failure have addressed the impact of kidney disease in the toxicity of GBCAs [11,35,57,67,75,76]. Nonetheless, they suggested that, in the case of renal disease, GBCAs decreased renal function [75], triggered skin fibrosis [11,57], increased the number of fibrocytes (related to the oxidative stress environment) [76], enhanced the differentiation of mononuclear cells into ferroportin-expressing fibrocystic cells [67], produced renal tube vacuolization [11], and caused disturbances in iron metabolism and TBARS values [75], as well as increased neutrophil count and neutrophil elastase activity [35].…”